An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents (Q46066669)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56419221)
(Q93106996)
(P304) 337-345
(P433) 2
(P478) 63
(P577) Tuesday, February 1, 2011
(P921) (Q181600)
(Q269829)
(Q187255)
(P1433) (Q4797636)
(P1476) "An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents" (language: en)
(P2093) Mark C Genovese
Michael E Weinblatt
Charles Peterfy
Michael L White
Maryann O'Brien
Elliott B Grossbard
Daniel B Magilavy
(P2860) (Q47643186)
(Q44774931)
(Q34795777)
(Q34609376)
(Q45946407)
(Q46271720)
(Q27860872)
(Q34315745)
(Q36171850)
(Q28294375)
(Q56974121)
other details
description scientific article

External Links